HIV Integrase Inhibitor Withdrawn Phase 2 Trials for Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00397566A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects